Home Cart Sign in  
Chemical Structure| 1959593-63-5 Chemical Structure| 1959593-63-5

Structure of Yimitasvir diphosphate
CAS No.: 1959593-63-5

Chemical Structure| 1959593-63-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Emitasvir phosphate, a small-molecule inhibitor of HCV non-structural protein 5A (NS5A) developed by HEC Pharm, was approved in China in 2020 for the treatment of liver cirrhosis-free genotype 1 hepatitis C patients. The product is in phase III clinical development for the treatment of patients suffering from chronic genotype 1 hepatitis C, in a combination regimen with furaprevir and ribavirin.

Synonyms: Emitasvir diphosphate; DAG-181 diphosphate

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Yimitasvir diphosphate

CAS No. :1959593-63-5
Formula : C49H64N8O14P2
M.W : 1051.03
SMILES Code : O=P(O)(O)O.COC(N[C@@H](C(C)C)C(N1[C@](CCC1)([H])C2=NC3=CC=C(C4=C5C([C@H]6C[C@@H]5CC6)=C(C7=CC=C(C8=CN=C([C@@]9([H])N(CCC9)C([C@H](C(C)C)NC(OC)=O)=O)N8)C=C7)C=C4)C=C3N2)=O)=O.O=P(O)(O)O
Synonyms :
Emitasvir diphosphate; DAG-181 diphosphate
MDL No. :N/A

Safety of Yimitasvir diphosphate

Isoform Comparison

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

0.95mL

0.19mL

0.10mL

4.76mL

0.95mL

0.48mL

9.51mL

1.90mL

0.95mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories